This study will focus on the side effects experienced by people with brain cancer who are taking adjuvant chemo (also called 5/23 or maintenance chemo).
Participants will gain access to navio’s tools to help manage their treatment, including a treatment calendar, medication reminders, and other resources. Sharing your experience will contribute insights to help others learn what to expect in their own treatment.
The information below is used to create a secure Navio account and will never be shared with any other party. We respect your privacy and you may opt out of the study at any time.
The study will begin in mid 2022. More information about us can be found at
www.navio.com